Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|May 13, 2022
Technical Design Report for a Carbon-11 Treatment FacilityLiviu Penescu, Thierry Stora, Simon Stegemann, et al.
EJNMMI Radiopharmacy and Chemistry|October 12, 2023
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?Maija Radzina, Laura Saule, Edgars Mamis, et al.
Scientific Reports|July 2, 2025
Quantification of trace <sup>227</sup>Ac and other radionuclidic impurities in mass-separated <sup>225</sup>Ac samples produced at CERN-MEDICISJake D Johnson, Cyril Bernerd, Frank Bruchertseifer, et al.
The Review of Scientific Instruments|March 8, 2013
First successful ionization of Lr (Z = 103) by a surface-ionization techniqueTetsuya K Sato, Nozomi Sato, Masato Asai, et al.
Frontiers in Medicine|August 5, 2021
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide TherapyMichiel Van de Voorde, Charlotte Duchemin, Reinhard Heinke, et al.
Frontiers in Medicine|September 23, 2021
The CERN-MEDICIS Isotope Separator BeamlineYisel Martinez Palenzuela, Vincent Barozier, Eric Chevallay, et al.
Scientific Reports|January 24, 2023
Resonant laser ionization and mass separation of <sup>225</sup>AcJake D Johnson, Michael Heines, Frank Bruchertseifer, et al.
EJNMMI Radiopharmacy and Chemistry|December 18, 2024
Novel radionuclides: demand, production and distribution for translational research in EuropeMaija Radzina, Laura Saule, Edgars Mamis, et al.
EJNMMI Research|June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing miceFrancesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Pharmaceutics|December 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATEKoen Vermeulen, Michiel Van de Voorde, Charlotte Segers, et al.
Pageof 3